Serving the Vulnerable: The World Health Organization's Scaled Support to Countries During the First Year of the COVID-19 Pandemic.

COVID-19 United Nations World Health Organization country-vulnerability emergency humanitarian pandemic

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 16 12 2021
accepted: 31 01 2022
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

The Inter-Agency Standing Committee (IASC), created by the United Nations (UN) General Assembly in 1991, serves as the global humanitarian coordination forum of the UN s system. The IASC brings 18 agencies together, including the World Health Organization (WHO), for humanitarian preparedness and response policies and action. Early in the COVID-19 pandemic, the IASC recognized the importance of providing intensified support to countries with conflict, humanitarian, or complex emergencies due to their weak health systems and fragile contexts. A Global Humanitarian Response Plan (GHRP) was rapidly developed in March 2020, which reflected the international support needed for 63 target countries deemed to have humanitarian vulnerability. This paper assessed whether WHO provided intensified technical, financial, and commodity inputs to GHRP countries (

Identifiants

pubmed: 35359755
doi: 10.3389/fpubh.2022.837504
pmc: PMC8960193
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

837504

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2022 Pereira Bajard, Stephens, Eidman, Warren, Molinaro, McDonough-Thayer, Rovaletti, Acharya, Graaff and Samaan.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Infect Dis. 2021 Jan;102:381-388
pubmed: 33130196
Lancet. 2021 Jul 10;398(10295):101-103
pubmed: 33991477
J Glob Health. 2021 Jul 03;11:03086
pubmed: 34221356
Front Public Health. 2022 Jan 18;9:831220
pubmed: 35118047

Auteurs

Micaela Pereira Bajard (M)

Country Strategy and Support, World Health Organization, Geneva, Switzerland.

Nicola Stephens (N)

World Health Organization, Geneva, Switzerland.

Johan Eidman (J)

COVID-19 Country Technical Support, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Kathleen Taylor Warren (KT)

COVID-19 Country Technical Support, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Paul Molinaro (P)

Operational Support and Logistics, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Constance McDonough-Thayer (C)

Operational Support and Logistics, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Rafael Rovaletti (R)

Budget Coordination and Grant Management, Planning, Resource Coordination and Performance Monitoring, World Health Organization, Geneva, Switzerland.

Shambhu P Acharya (SP)

Country Strategy and Support, World Health Organization, Geneva, Switzerland.

Peter J Graaff (PJ)

Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Gina Samaan (G)

COVID-19 Country Technical Support, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH